Previous close | 11.50 |
Open | 15.30 |
Bid | 14.90 |
Ask | 17.70 |
Strike | 540.00 |
Expiry date | 2025-06-20 |
Day's range | 13.95 - 16.40 |
Contract range | N/A |
Volume | |
Open interest | 6 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning